Protalix BioTherapeutics Inc (PLX)
1.18
-0.03
(-2.48%)
USD |
NYAM |
Apr 25, 16:00
1.20
+0.02
(+1.69%)
Pre-Market: 20:00
Protalix BioTherapeutics Market Cap: 86.20M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 86.20M |
| April 24, 2024 | 88.39M |
| April 23, 2024 | 87.66M |
| April 22, 2024 | 86.20M |
| April 19, 2024 | 84.01M |
| April 18, 2024 | 82.55M |
| April 17, 2024 | 84.01M |
| April 16, 2024 | 83.28M |
| April 15, 2024 | 83.28M |
| April 12, 2024 | 86.20M |
| April 11, 2024 | 89.12M |
| April 10, 2024 | 92.05M |
| April 09, 2024 | 96.43M |
| April 08, 2024 | 94.97M |
| April 05, 2024 | 85.47M |
| April 04, 2024 | 88.39M |
| April 03, 2024 | 90.58M |
| April 02, 2024 | 90.58M |
| April 01, 2024 | 91.32M |
| March 28, 2024 | 92.05M |
| March 27, 2024 | 91.32M |
| March 26, 2024 | 89.12M |
| March 25, 2024 | 89.12M |
| March 22, 2024 | 92.78M |
| March 21, 2024 | 96.43M |
| Date | Value |
|---|---|
| March 20, 2024 | 97.89M |
| March 19, 2024 | 94.97M |
| March 18, 2024 | 92.78M |
| March 15, 2024 | 97.16M |
| March 14, 2024 | 100.08M |
| March 13, 2024 | 111.04M |
| March 12, 2024 | 104.46M |
| March 11, 2024 | 105.20M |
| March 08, 2024 | 108.85M |
| March 07, 2024 | 106.66M |
| March 06, 2024 | 108.12M |
| March 05, 2024 | 111.04M |
| March 04, 2024 | 114.69M |
| March 01, 2024 | 118.34M |
| February 29, 2024 | 118.91M |
| February 28, 2024 | 112.35M |
| February 27, 2024 | 113.81M |
| February 26, 2024 | 108.70M |
| February 23, 2024 | 105.78M |
| February 22, 2024 | 104.32M |
| February 21, 2024 | 103.59M |
| February 20, 2024 | 105.05M |
| February 16, 2024 | 107.24M |
| February 15, 2024 | 110.89M |
| February 14, 2024 | 107.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.06M
Minimum
Oct 14 2019
282.28M
Maximum
Apr 23 2021
91.09M
Average
82.84M
Median
Feb 13 2023
Market Cap Benchmarks
| Agenus Inc | 173.85M |
| InfuSystems Holdings Inc | 161.82M |
| Corbus Pharmaceuticals Holdings Inc | 351.99M |
| AIM ImmunoTech Inc | 20.28M |
| Armata Pharmaceuticals Inc | 91.48M |
Market Cap Related Metrics
| PE Ratio | 59.00 |
| PS Ratio | 1.401 |
| Price to Book Value | 2.568 |
| Price | 1.18 |
| Earnings Yield | 1.69% |
| Operating PE Ratio | 8.772 |
| Normalized PE Ratio | 59.00 |